Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab

Background: Asthma is a clinical syndrome characterized by recurrent episodes of airway obstruction, bronchial hyperresponsiveness and airway inflammation. Most patients with asthma present a “type 2” (TH2) inflammation. ILC2 and TH2 cells release cytokines IL4, IL-13 and IL-5. CRSwNP is a condition...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Andrea Giovanni Ledda, Giulia Costanzo, Giada Sambugaro, Cristiano Caruso, Martina Bullita, Maria Luisa Di Martino, Paolo Serra, Davide Firinu, Stefano Del Giacco
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2023-09-01
Serija:	Life
Teme:	asthma nasal polyps eosinophils cationic protein dupilumab biomarkers type 2 inflammation
Online dostop:	https://www.mdpi.com/2075-1729/13/9/1884
Oznake:	Označite Brez oznak, prvi označite!